PriceSensitive

Little Green Pharma (ASX:LGP) buds cannabis oil distribution agreement in Germany

ASX News, Health Care
ASX:LGP      MCAP $36.21M
19 January 2022 11:09 (AEST)
Little Green Pharma (ASX:LGP) - Managing Director, Fleta Solomon

Source: LGP

Little Green Pharma (LGP) has entered a three-year distribution agreement to market its LGP cannabis oils in Germany.

Under the exclusive agreement with AMP Medical Products, AMP will distribute and market LGP cannabis oil medicines, while agreeing not to promote any other oil products in Germany.

AMP currently holds one of the largest medical liaison teams in Germany and hosts a broad range of well-attended medicinal cannabis education sessions for physicians and allied health professionals.

In return, Little Green Pharma will supply AMP s with its 10:10 LGP Classic and 20:5 LGP Classic cannabis oils on an exclusive basis.

The agreement is conditional upon AMP completing a supplier qualification into LGP, which LGP estimates will complete during the second quarter of 2022.

Under the Agreement, AMP must purchase a minimum annual quantity of at least 2000 50 millilitre units within the first year, and 5000 units in the second year, provided that if Little Green Pharma distributes LGP branded oils on its own account, the quantities in the second and third years are reduced by 50 per cent.

AMP must also ensure that at least 10 per cent of the minimum annual quantities purchased are non-exclusive oil products.

If AMP fails to meet the minimum quarterly quantity for any two quarters, Little Green Pharma may cancel AMP’s exclusivity.

If there are any unsold products that have expired at the end of year one, LGP will be required to reimburse AMP with 50 per cent of the amount paid for these products.

Little Green Pharma was up 1.69 per cent to 60 cents at 11:06 am AEDT.

Related News